An Observational Study of Pegasys and Copegus in Treatment-Naive Patients With Chronic Hepatitis C

Mise à jour : Il y a 4 ans
Référence : NCT01659567

Femme et Homme

  • | Pays :
  • Georgia
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

This prospective observational study will investigate predictive values of virological response in peginterferon/ribavirin treatment-naive patients with chronic hepatitis C. Patients will be treated with Pegasys (peg-interferon alpha 2a) and Copegus (ribavirin) as prescribed by the physician. Data will be collected for 72 weeks.


Critère d'inclusion

  • Hepatitis C, Chronic

Liens